Trials / Unknown
UnknownNCT01979965
Effect of Ranolazine on Valvular Disease in Patients With Pacemakers
Ranolazine Effects on Ischemic Mitral Regurgitation Severity in Patients With Cardiac Resynchronization Therapy
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- University Cardiology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out whether mitral regurgitation (or a leaky heart valve) caused by ischemic heart disease (decreased blood flow to heart muscle) will improve after administration of ranolazine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ranolazine (Active drug) | Ranolazine therapy for three months |
| DRUG | Placebo | Placebo therapy for three months |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-05-01
- Completion
- 2014-09-01
- First posted
- 2013-11-08
- Last updated
- 2013-11-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01979965. Inclusion in this directory is not an endorsement.